| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 3 securities · may seek to influence control | ||||||
|
Datavault AI Inc.
13D/A
DVLT · 86633R609
|
17.2% |
8/24/2026
Event 8/20/2026
|
||||
|
Semnur Pharmaceuticals, Inc.
13D/A
SMNRW · 81686G113
|
78.9% |
6/26/2026
Event 6/15/2026
|
||||
| Scilex Holding Company | 78.9% | |||||
| Scilex, Inc. | 75.9% | |||||
|
Semnur Pharmaceuticals, Inc.
13D
SMNRW · 81686G113
|
79.9% |
9/26/2025
Event 9/22/2025
|
||||
| Scilex Holding Company | 79.9% | |||||
| Scilex, Inc. | 77.0% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.